1. Published

   Have infection control and prevention measures resulted in any adverse outcomes for care home and domiciliary care residents and staff? Report number: RR_00018 (November 2021)

   Spencer, L., Hartfiel, N., Hendry, A., Anthony, B., Makanjuola, A., Bray, N., Hughes, D., Wilkinson, C., Fitzsimmons, D. & Edwards, R. T., 1 Nov 2021, 36 p.

   Research output: Book/Report › Other report › peer-review

2. Published

   HTAs and rare diseases: How to assess their cost-effectiveness

   Hughes, D., Phillips, C. J. & Hughes, D. A., 1 Nov 2011, In: Pharmaceuticals Policy and Law. 13, 3-4, p. 161-165

   Research output: Contribution to journal › Article › peer-review

3. Published

   HLA-B*5701 and abacavir hypersensitivity - Reply.

   Hughes, D., Hughes, D. A., Park, B. K. & Pirmohamed, M., 1 Nov 2004, In: Pharmacogenetics. 14, 11, p. 784

   Research output: Contribution to journal › Article › peer-review

4. Published

   Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study.

   Hughes, D., Jorgensen, A. L., Al-Zubiedi, S., Zhang, J. E., Keniry, A., Hanson, A., Hughes, D. A., Van Eker, D., Stevens, L., Hawkins, K., Toh, C. H., Kamali, F., Daly, A. K., Fitzmaurice, D., Coffey, A., Williamson, P. R., Park, B. K., Deloukas, P. & Pirmohamed, M., 1 Oct 2009, In: Pharmacogenetics and Genomics. 19, 10, p. 800-812

   Research output: Contribution to journal › Article › peer-review

5. Published

   Generic and therapeutic substitutions in the UK: are they a good thing?

   Hughes, D., Duerden, M. G. & Hughes, D. A., 1 Sept 2010, In: British Journal of Clinical Pharmacology. 70, 3, p. 335-341

   Research output: Contribution to journal › Article › peer-review

6. Published

   Generalisability and Cost-Impact of Antibiotic-Impregnated Central Venous Catheters for Reducing Risk of Bloodstream Infection in Paediatric Intensive Care Units in England

   Harron, K., Mok, Q., Hughes, D., Muller-Pebody, B., Parslow, R., Ramnarayan, P. & Gilbert, R., 21 Mar 2016, In: PLoS ONE. 11, 3, p. e0151348

   Research output: Contribution to journal › Article › peer-review

7. Published

   From efficacy to effectiveness and cost-effectiveness: modelling possibilities

   Hughes, D. & Hughes, D. A., 1 Nov 2004.

   Research output: Contribution to conference › Paper

8. Published

   From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics

   Hughes, D. & Hughes, D. A., 1 May 2002.

   Research output: Contribution to conference › Paper

9. Published

   From efficacy to cost-effectiveness: Impact of patient compliance

   Hughes, D. & Hughes, D. A., 1 Feb 2008.

   Research output: Contribution to conference › Paper

10. Published

    From NCE to NICE: the role of pharmacoeconomics

    Hughes, D. & Hughes, D. A., 1 Sept 2010, In: British Journal of Clinical Pharmacology. 70, 3, p. 317-319

    Research output: Contribution to journal › Article › peer-review